Dental management of patients taking antiplatelet, oral anticoagulant and novel anticoagulant medications

Branislav  Bajkin; Siniša Mirković; Predrag Vučinić; Biljana Vučković; Marjan Marjanović

doi:10.2298/VSP170719128B

Branislav Bajkin University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia
Siniša Mirković University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia
Predrag Vučinić University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia
Biljana Vučković University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia
Marjan Marjanović University Bussines Academy Novi Sad, Faculty of Stomatology Pančevo, Department for Oral Surgery, Pančevo, Serbi

DOI: https://doi.org/10.2298/VSP170719128B

Keywords: tooth diseases;, fibrinolitic agents;, anticoagulants;, oral surgical procedures;, treatment outcome.

Author Biography

Branislav Bajkin, University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia

Doktor stomatologije

Doktor medicine

Specijalista oralne hirurgije

Docent na Katedri za stomatologiju, Medicinski fakultet Novi Sad

References

Siegal DM, Crowther MA. Acute management of bleeding in patients on novel oral anticoagulants. Eur Heart J 2013; 34(7): 489–498b.

Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G. Oral anticoagulant therapy: Antithrombotic Thera-py and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guide-lines. Chest 2012; 141(2 Suppl): e44S–e88S.

Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for pre-vention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324(7329): 71–86.

Antithrombotic Trialists' (ATT) Collaboration, Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009; 373(9678): 1849–60.

Eikelboom JW, Hirsh J, Spencer FA, Baglin TP, Weitz JI. An-tiplatelet drugs: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Ev-idence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl): e89S–e119S.

Brennan MT, Wynn RL, Miller CS. Aspirin and bleeding in den-tistry: An update and recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 104(3): 316–23.

Nagao Y, Masuda R, Ando A, Nonaka M, Nishimura A, Goto K, et al. Whole blood platelet aggregation test and prediction of hemostatic difficulty after tooth extraction in patients receiv-ing antiplatelet therapy. Clin Appl Thromb Hemost 2018; 24(1): 151–6.

Biondi-Zoccai GG, Lotrionte M, Agostoni P, Abbate A, Fusaro M, Burzotta F, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 2006; 27(22): 2667–74.

Burger W, Chemnitius JM, Kneissl GD, Rücker G. Low-dose as-pirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med 2005; 257(5): 399–414.

Maulaz AB, Bezerra DC, Michel P, Bogousslavsky J. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol 2005; 62(8): 1217–20.

Ferrari E, Benhamou M, Cerboni P, Marcel B. Coronary syn-dromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol 2005; 45(3): 456–9.

Bajkin BV, Urosevic IM, Stankov KM, Petrovic BB, Bajkin IA. Dental extractions and risk of bleeding in patients taking sin-gle and dual antiplatelet treatment. Br J Oral Maxillofac Surg 2015; 53(1): 39–43.

Napeñas JJ, Oost FC, DeGroot A, Loven B, Hong CH, Brennan MT, et al. Review of postoperative bleeding risk in dental pa-tients on antiplatelet therapy. Oral Surg Oral Med Oral Pathol Oral Radiol 2013; 115(4): 491–9.

Morimoto Y, Niwa H, Minematsu K. Risk factors affecting post-operative hemorrhage after tooth extraction in patients re-ceiving oral antithrombotic therapy. J Oral Maxillofac Surg 2011; 69(6): 1550–6.

Lillis T, Ziakas A, Koskinas K, Tsirlis A, Giannoglou G. Safety of dentalextractions during uninterrupted single or dual an-tiplatelet treatment. Am J Cardiol 2011; 108(7): 964–7.

Wahl MJ. Dental Surgery and Antiplatelet Agents: Bleed or Die. Am J Med 2014; 127(4): 260–7.

Grines CL, Bonow RO, Casey DE Jr, Gardner TJ, Lockhart PB, Moliterno DJ, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Associa-tion, American College of Cardiology, Society for Cardiovas-cular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representa-tion from the American College of Physicians. Circulation 2007; 115(6): 813–8.

Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, et al. Perioperative management of antithrom-botic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl): e326S–e350S.

Park M, Her S, Kwon JB, Lee JB, Choi M, Cho JS, et al. Safety of dental extractions in coronary drug-eluting stenting patients without stopping multiple antiplatelet agents. Clin Cardiol 2012; 35(4): 225–30.

Sadeghi-Ghahrody M, Yousefi-Malekshah SH, Karimi-Sari H, Yazdanpanah H, Rezaee-Zavareh MS, Yavarahmadi M. Bleeding after tooth extraction in patients taking aspirin andclopidogrel (Plavix®) compared with healthy controls. Br J Oral Maxillo-fac Surg 2016; 54(5): 568–72.

Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ. American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: Antithrombotic Therapy and Prevention of Throm-bosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guideline. Chest 2012; 141(Suppl 2): 7S–47S.

Keeling K, Baglin T, Tait C, Watson H, Perry D, Baglin C, et al. British Committee for Standards in Haematology: Guidelines on oral anticoagulation with warfarin-fourth edition. Br J Haematol 2011; 154(3): 311–24.

Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28(2): 230–68.

Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Asso-ciation/American College of Cardiology Foundation. Ameri-can Heart Association/American College of Cardiology Foun-dation guide to warfarin therapy. J Am Coll Cardiol 2003; 41(9): 1633–52.

Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. American College of Chest Physicians. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guide-lines (8th Edition). Chest 2008; 133(Suppl 6): 160S–98S.

Carter G, Goss AN, Lloyd J, Tocchetti R. Current concepts of the management of dental extractions for patients taking war-farin. Aust Dent J 2003; 48(2): 89–96; quiz 138.

du Breuil AL, Umland EM. Outpatient management of antico-agulation therapy. Am Fam Physician 2007; 75(7): 1031–42.

Jeske AH, Suchko GD. ADA Council on Scientific Affairs and Division of Science; Journal of the American Dental Associa-tion. Lack of a scientific basis for routine discontinuation of oral anticoagulation therapy before dental treatment. J Am Dent Assoc 2003; 134(11): 1492–7.

Aframian DJ, Lalla RV, Peterson DE. Management of dental patients taking common hemostasis-altering medications. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103 Suppl: S45.e1–11.

Bajkin BV, Popovic SL, Selakovic SD. Randomized, prospective trial comparing bridging therapy using low-molecular-weight heparin with maintenance of oral anticoagulation during ex-traction of teeth. J Oral Maxillofac Surg 2009; 67(5): 990–5.

Aldridge E, Cunningham LL Jr. Current thoughts on treatment of patients receiving anticoagulation therapy. J Oral Maxillo-fac Surg 2010; 68(11): 2879–87.

Bacci C, Maglione M, Favero L, Perini A, Di Lenarda R, Berengo M, et al. Management of dental extraction in patients under-going anticoagulant treatment. Results from a large, multicen-tre, prospective, case-control study. Thromb Haemost 2010; 104(5): 972–5.

Bajkin BV, Todorovic LM. Safety of local anaesthesia in dental patients taking oral anticoagulants: Is it still controversial. Br J Oral Maxillofac Surg 2012; 50(1): 65–8.

Bajkin BV, Bajkin IA, Petrovic BB. The effects of combined oral anticoagulant-aspirin therapy in patients undergoing tooth extractions: A prospective study. J Am Dent Assoc 2012; 143(7): 771–6.

Eichhorn W, Burkert J, Vorwig O, Blessmann M, Cachovan G, Zeuch J, et al. Bleeding incidence after oral surgery with con-tinued oral anticoagulation. Clin Oral Investig 2012; 16(5): 1371–6.

Hong C, Napenas JJ, Brennan M, Furney S, Lockhart P. Risk of postoperative bleeding after dental procedures in patients on warfarin: A retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol 2012; 114(4): 464–8.

Broekema FI, Minnen B, Jansma J, Bos RR. Risk of bleeding af-ter dentoalveolar surgery in patients taking anticoagulants. Br J Oral Maxillofac Surg 2014; 52(3): e15–9.

Wahl MJ, Pinto A, Kilham J, Lalla RV. Dental surgery in anti-coagulated patients-stop the interruption. Oral Surg Oral Med Oral Pathol Oral Radiol 2015; 119(2): 136–57.

Marjanović M. Use of thrombin powder after tooth extraction in patients receiving anticoagulant therapy. Vojnosanit Pregl 2002; 59(4): 389–92. (Serbian)

Bajkin BV, Rajic NV, Vujkov SB. Dental extraction in a he-mophilia patient without factor replacement therapy: a case report. J Oral Maxillofac Surg 2012; 70(10): 2276–7.

Bajkin BV, Selaković SD, Mirković SM, Šarčev IN, Tadič AJ, Milekič BR. Comparison of efficacy of local hemostatic modal-ities in anticoagulated patients undergoing tooth extractions. Vojnosanit Pregl 2014; 71(12): 1097–101.

Salem DN, O'Gara PT, Madias C, Pauker SG. Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133(6 Suppl): 593S–629S.

Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, et al. 2006 Writing Committee Members; American College of Cardiology/American Heart Association Task Force. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118(15): e523–661.

Dentali F, Douketis JD, Lim W, Crowther M. Combined aspiri-noral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular dis-ease: A metaanalysis of randomized trials. Arch Intern Med 2007; 167(2): 117–24.

Akins PT, Feldman HA, Zoble RG, Newman D, Spitzer SG, Diener HC, et al. Secondary stroke prevention with ximela-gatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials. Stroke 2007; 38(3): 874–80.

Douketis JD, Arneklev K, Goldhaber SZ, Spandorfer J, Halperin F, Horrow J. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: As-sessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding. Arch Intern Med 2006; 166(8): 853–9.

Little JW. New oral anticoagulants: Will they replace warfarin? Oral Surg Oral Med Oral Pathol Oral Radiol 2012; 113(5): 575–80.

Firriolo JF, Hupp WS. Beyond warfarin: the new generation of oral anticoagulants and their implications for the management of dental patients. Oral Surg Oral Med Oral Pathol Oral Ra-diol 2012; 113(4): 431–41.

Costantinides F, Rizzo R, Pascazio L, Maglione M. Managing pa-tients taking novel oral anticoagulants (NOAs) in dentistry: a discussion paper on clinical implications. BMC Oral Health 2016; 16: 5.

Breik O, Cheng A, Sambrook P, Goss A. Protocol in managing oral surgical patients taking dabigatran. Aust Dent J 2014; 59(3): 296–301; quiz 401.

Connolly S, Ezekowitz M, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fi-brillation. N Engl J Med 2009; 361(12): 1139–51.

Mauprivez C, Khonsari RH, Razouk O, Goudot P, Lesclous P, Descroix V. Management of dental extraction in patients un-dergoing anticoagulant oral direct treatment: A pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol 2016; 122(5): e146–e155.

Healey JS, Eikelboom J, Douketis J, Wallentin L, Oldgren J, Yang S, et al. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Ther-apy (RE-LY) randomized trial. Circulation 2012; 126(3): 343–8.

Johnston S. An evidence summary of the management of pa-tients taking direct oral anticoagulants (DOACs) undergoing dental surgery. Int J Oral Maxillofac Surg 2016; 45(5): 618–30.

Muñoz-Corcuera M, Ramírez-Martínez-Acitores L, López-Pintor RM, Casañas-Gil E, Hernández-Vallejo G. Dabigatran: A new oral anticoagulant. Guidelines to follow in oral surgery proce-dures. A systematic review of the literature. Med Oral Patol Oral Cir Bucal 2016; 21(6): e679–e688.

Lusk KA, Snoga JL, Benitez RM, Sarbacker GB. Management of Direct-Acting Oral Anticoagulants Surrounding Dental Pro-cedures With Low-to-Moderate Risk of Bleeding. J Pharm Pract 2017; 1: 897190017707126.

Miclotte I, Vanhaverbeke M, Agbaje JO, Legrand P, Vanassche T, Verhamme P, et al. Pragmatic approach to manage new oral anticoagulants in patients undergoing dental extractions: A prospective case-control study. Clin Oral Investig 2017; 21(7): 2183–8.

van Diermen DE, van der Waal I, Hoogstraten J. Management recommendations for invasive dental treatment in patients us-ing oral antithrombotic medication, including novel oral anti-coagulants. Oral Surg Oral Med Oral Pathol Oral Radiol 2013; 116(6): 709–16.

Thean D, Alberghini M. Anticoagulant therapy and its impact on dental patients: A review. Aust Dent J 2016; 61(2): 149–56.

Sivolella S, De Biagi M, Brunello G, Berengo M, Pengo V. Manag-ing dentoalveolar surgical procedures in patients taking new oral anticoagulants. Odontology 2015; 103(3): 258–63.

ROCKET AF Study Investigators. Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K an-tagonism for prevention of stroke and Embolism Trial in Atri-al Fibrillation: rationale and design of the ROCKET AF study. Am Heart J 2010; 159(3): 340–347.e1.

Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365(10): 883–91.

Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus warfarin in patients with atri-al fibrillation. N Engl J Med 2011; 365(11): 981–92.

Morimoto Y, Yokoe C, Imai Y, Sugihara M, Futatsuki T. Tooth extraction in patients taking nonvitamin K antagonist oral an-ticoagulants. J Dent Sci 2016; 11(1): 59–64.